Literature DB >> 17079295

Sheep-passaged bovine spongiform encephalopathy agent exhibits altered pathobiological properties in bovine-PrP transgenic mice.

Juan Carlos Espinosa1, Olivier Andréoletti, Joaquín Castilla, María Eugenia Herva, Mónica Morales, Elia Alamillo, Fayna Díaz San-Segundo, Caroline Lacroux, Séverine Lugan, Francisco Javier Salguero, Jan Langeveld, Juan María Torres.   

Abstract

Sheep can be experimentally infected with bovine spongiform encephalopathy (BSE), and the ensuing disease is similar to scrapie in terms of pathogenesis and clinical signs. BSE infection in sheep is an animal and human health concern. In this study, the transmission in BoPrP-Tg110 mice of prions from BSE-infected sheep was examined and compared to the transmission of original cattle BSE in cattle and sheep scrapie prions. Our results indicate no transmission barrier for sheep BSE prions to infect BoPrP-Tg110 mice, but the course of the disease is accelerated compared to the effects of the original BSE isolate. The shortened incubation period of sheep BSE in the model was conserved in subsequent passage in BoPrP-Tg110 mice, indicating that it is not related to infectious titer differences. Biochemical signature, lesion profile, and PrP(Sc) deposition pattern of both cattle and sheep BSE were similar. In contrast, all three sheep scrapie isolates tested showed an evident transmission barrier and further adaptation in subsequent passage. Taken together, those data indicate that BSE agent can be altered by crossing a species barrier, raising concerns about the virulence of this new prion towards other species, including humans. The BoPrP-Tg110 mouse bioassay should be considered as a valuable tool for discriminating scrapie and BSE in sheep.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17079295      PMCID: PMC1797487          DOI: 10.1128/JVI.01356-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Prion diseases: BSE in sheep bred for resistance to infection.

Authors:  Fiona Houston; Wilfred Goldmann; Angela Chong; Martin Jeffrey; Lorenzo González; James Foster; David Parnham; Nora Hunter
Journal:  Nature       Date:  2003-05-29       Impact factor: 49.962

2.  The possible nature of the transmissible agent of scrapie.

Authors:  I H Pattison; K M Jones
Journal:  Vet Rec       Date:  1967-01-07       Impact factor: 2.695

3.  Scrapie in the welsh mountain breed of sheep and its experimental transmission to goats.

Authors:  I H Pattison
Journal:  Vet Rec       Date:  1965-11-20       Impact factor: 2.695

4.  The sequential development of the brain lesion of scrapie in three strains of mice.

Authors:  H Fraser; A G Dickinson
Journal:  J Comp Pathol       Date:  1968-07       Impact factor: 1.311

5.  Proteinase K enhanced immunoreactivity of the prion protein-specific monoclonal antibody 2A11.

Authors:  Alejandro Brun; Joaquín Castilla; Miguel A Ramírez; Kai Prager; Beatriz Parra; Francisco J Salguero; Diane Shiveral; Carmen Sánchez; José M Sánchez-Vizcaíno; Alastair Douglas; Juan M Torres
Journal:  Neurosci Res       Date:  2004-01       Impact factor: 3.304

6.  Maternal transmission studies of BSE in sheep.

Authors:  J D Foster; W Goldmann; C McKenzie; A Smith; D W Parnham; N Hunter
Journal:  J Gen Virol       Date:  2004-10       Impact factor: 3.891

7.  Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes.

Authors:  M Scott; D Groth; D Foster; M Torchia; S L Yang; S J DeArmond; S B Prusiner
Journal:  Cell       Date:  1993-06-04       Impact factor: 41.582

8.  Discrimination between scrapie and bovine spongiform encephalopathy in sheep by molecular size, immunoreactivity, and glycoprofile of prion protein.

Authors:  C M A Thuring; J H F Erkens; J G Jacobs; A Bossers; L J M Van Keulen; G J Garssen; F G Van Zijderveld; S J Ryder; M H Groschup; T Sweeney; J P M Langeveld
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

9.  Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD.

Authors:  Silvio Notari; Sabina Capellari; Armin Giese; Ingo Westner; Agostino Baruzzi; Bernardino Ghetti; Pierluigi Gambetti; Hans A Kretzschmar; Piero Parchi
Journal:  J Biol Chem       Date:  2004-01-29       Impact factor: 5.157

10.  Different behavior toward bovine spongiform encephalopathy infection of bovine prion protein transgenic mice with one extra repeat octapeptide insert mutation.

Authors:  J Castilla; A Gutiérrez-Adán; A Brun; B Pintado; B Parra; M A Ramírez; F J Salguero; F Díaz San Segundo; A Rábano; M J Cano; J M Torres
Journal:  J Neurosci       Date:  2004-03-03       Impact factor: 6.167

View more
  39 in total

Review 1.  In vitro studies of the transmission barrier.

Authors:  Natalia Fernández-Borges; Jorge de Castro; Joaquín Castilla
Journal:  Prion       Date:  2009-10-30       Impact factor: 3.931

2.  Does the Presence of Scrapie Affect the Ability of Current Statutory Discriminatory Tests To Detect the Presence of Bovine Spongiform Encephalopathy?

Authors:  M M Simmons; M J Chaplin; C M Vickery; S Simon; L Davis; M Denyer; R Lockey; M J Stack; M J O'Connor; K Bishop; K C Gough; B C Maddison; L Thorne; J Spiropoulos
Journal:  J Clin Microbiol       Date:  2015-06-03       Impact factor: 5.948

3.  Role of the goat K222-PrP(C) polymorphic variant in prion infection resistance.

Authors:  Patricia Aguilar-Calvo; Juan Carlos Espinosa; Belén Pintado; Alfonso Gutiérrez-Adán; Elia Alamillo; Alberto Miranda; Irene Prieto; Alex Bossers; Olivier Andreoletti; Juan María Torres
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

4.  Assessing the susceptibility of transgenic mice overexpressing deer prion protein to bovine spongiform encephalopathy.

Authors:  Christopher M Vickery; Richard Lockey; Thomas M Holder; Leigh Thorne; Katy E Beck; Christina Wilson; Margaret Denyer; John Sheehan; Sarah Marsh; Paul R Webb; Ian Dexter; Angela Norman; Emma Popescu; Amanda Schneider; Paul Holden; Peter C Griffiths; Jane M Plater; Mark P Dagleish; Stuart Martin; Glenn C Telling; Marion M Simmons; John Spiropoulos
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

5.  Molecular and transmission characteristics of primary-passaged ovine scrapie isolates in conventional and ovine PrP transgenic mice.

Authors:  Alana M Thackray; Lee Hopkins; John Spiropoulos; Raymond Bujdoso
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

6.  PrPC Governs Susceptibility to Prion Strains in Bank Vole, While Other Host Factors Modulate Strain Features.

Authors:  J C Espinosa; R Nonno; M Di Bari; P Aguilar-Calvo; L Pirisinu; N Fernández-Borges; I Vanni; G Vaccari; A Marín-Moreno; P Frassanito; P Lorenzo; U Agrimi; J M Torres
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

7.  Molecular behaviors of "CH1641-like" sheep scrapie isolates in ovine transgenic mice (TgOvPrP4).

Authors:  Thierry Baron; Anne-Gaëlle Biacabe
Journal:  J Virol       Date:  2007-04-18       Impact factor: 5.103

8.  Exploring the risks of a putative transmission of BSE to new species.

Authors:  Enric Vidal; Natalia Fernández-Borges; Belén Pintado; Montserrat Ordóñez; Mercedes Márquez; Dolors Fondevila; Hasier Eraña; Juan María Torres; Martí Pumarola; Joaquín Castilla
Journal:  Prion       Date:  2013-11-01       Impact factor: 3.931

9.  Enhanced virulence of sheep-passaged bovine spongiform encephalopathy agent is revealed by decreased polymorphism barriers in prion protein conversion studies.

Authors:  Jan Priem; Jan P M Langeveld; Lucien J M van Keulen; Fred G van Zijderveld; Olivier Andreoletti; Alex Bossers
Journal:  J Virol       Date:  2013-12-26       Impact factor: 5.103

10.  Transgenic mice expressing porcine prion protein resistant to classical scrapie but susceptible to sheep bovine spongiform encephalopathy and atypical scrapie.

Authors:  Juan Carlos Espinosa; María Eugenia Herva; Olivier Andréoletti; Danielle Padilla; Caroline Lacroux; Hervé Cassard; Isabelle Lantier; Joaquin Castilla; Juan Maria Torres
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.